Norwegian version
Employee directory
Nina Ånensen

Nina Ånensen

Job title
  • Senior Adviser
Visiting address
  • Pilestredet 32, 0166 Oslo
  • Office number: N100.034
Phone
  • Mobile: +47 930 07 407
  • Office: +47 672 35 876
E-mail
  • nina.anensen@oslomet.no
Affiliation

Administrative field of work

Research cooperation agreements   Cristin   EU   Funding   Research quality   Research collaboration   Research strategy

Publications and research

Scientific publications

Ånensen, Nina ; Hjelle, Sigrun Margrethe; Van, Belle Werner; Haaland, Ingvild; Silden, Elisabeth; Bourdon, Jean-Christophe; Hovland, Randi; Tasken, Kjetil; Knappskog, Stian; Lønning, Per Eystein; Bruserud, Øystein; Gjertsen, Bjørn Tore (2012). Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia. Oncogene. Vol. 31.
https://doi.org/10.1038/onc.2011.348

Øyan, Anne Margrete; Ånensen, Nina ; Bø, Trond Hellem; Stordrange, Laila; Jonassen, Inge; Bruserud, Øystein; Kalland, Karl-Henning; Gjertsen, Bjørn Tore (2009). Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia. BMC Cancer. Vol. 9.
https://doi.org/10.1186/1471-2407-9-77

Ånensen, Nina ; Øyan, Anne Margrete; Huseby, Sjur; Kalland, Karl-Henning; Bruserud, Øystein; Gjertsen, Bjørn Tore (2007). Early gene expression of acute myeloid leukemia in response to chemotherapy. Expert Review of Anticancer Therapy. Vol. 7.
https://doi.org/10.1586/14737140.7.5.741

Irish, Jonathan C.; Ånensen, Nina ; Hovland, Randi; Skavland, Jørn; Børresen-Dale, Anne-Lise; Bruserud, Øystein; Nolan, Gary P; Gjertsen, Bjørn Tore (2007). Flt3 Y591 duplication and Bc1-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53. Blood. Vol. 109.
https://doi.org/10.1182/blood-2006-02-004234

Ersvær, Elisabeth; Zhang, Jian-Ying; McCormack, Emmet Martin; Olsnes, Astrid Marta; Ånensen, Nina ; Tan, Eng M.; Gjertsen, Bjørn Tore; Bruserud, Øystein (2007). Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. European Journal of Haematology. Vol. 79.
https://doi.org/10.1111/j.1600-0609.2007.00899.x

Gjertsen, Bjørn Tore; Bredholt, Therese; Ånensen, Nina ; Vintermyr, Olav (2007). Bcl-2 antisense in the treatment of human malignancies: A delusion in targeted therapy. Current Pharmaceutical Biotechnology. Vol. 8.
https://doi.org/10.2174/138920107783018381

Ånensen, Nina ; Øyan, Anne Margrete; Bourdon, Jean-Christophe; Kalland, Karl-Henning; Bruserud, Øystein; Gjertsen, Bjørn Tore (2006). A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. Clinical Cancer Research. Vol. 12.
https://doi.org/10.1158/1078-0432.CCR-05-1970

Belle, Werner Van; Ånensen, Nina ; Haaland, Ingvild; Bruserud, Øystein; Høgda, Kjell-Arild; Gjertsen, Bjørn Tore (2006). Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables. BMC Bioinformatics. Vol. 7.
https://doi.org/10.1186/1471-2105-7-198

Bruserud, Øystein; Stapnes, Camilla I; Tronstad, Karl Johan; Ryningen, Anita; Ånensen, Nina ; Gjertsen, Bjørn Tore (2006). Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML. Expert opinion on therapeutic targets. Vol. 10.
https://doi.org/10.1517/14728222.10.1.51

Ånensen, Nina ; Haaland, Ingvild; Santos, Clive D; Belle, Werner Van; Gjertsen, Bjørn Tore (2006). Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia. Current Pharmaceutical Biotechnology. Vol. 7.
https://doi.org/10.2174/138920106777549731



See all publications


These publications are obtained from Norwegian Research Information Repository. The list may be incomplete.

Research reports

Ånensen, Nina ; Gjertsen, Bjørn Tore (2006). p53 protein biosignatures in acute myeloid leukemia. ISBN: 9788230801277. Universitetet i Bergen.
https://hdl.handle.net/1956/1554



These publications are obtained from Norwegian Research Information Repository. The list may be incomplete.

Dissemination

Ånensen, Nina ; Skavland, Jørn; Stapnes, Camilla I; Ryningen, Anita; Børresen-Dale, Anne-Lise; Gjertsen, Bjørn Tore; Bruserud, Øystein (2006). Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report. Leukemia. Vol. 20.
https://doi.org/10.1038/sj.leu.2404117

Øyan, Anne Margrete; Ånensen, Nina ; Bø, Trond Hellem; Stordrange, Laila; Jonassen, Inge; Bruserud, Øystein; Kalland, Karl-Henning; Gjertsen, Bjørn Tore (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy. 7th Bergen Conference on Cancer Research. LOCUS for Cancer Research, University of Bergen.
https://hdl.handle.net/11250/5132116

Øyan, Anne Margrete; Ånensen, Nina ; Bø, Trond Hellem; Stordrange, Laila; Jonassen, Inge; Bruserud, Øystein; Kalland, Karl-Henning; Gjertsen, Bjørn Tore (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy. 11th World Congress on Advances in Oncology. Medical School, University of Crete.
https://hdl.handle.net/11250/4053669

Sandal, Tone; Krakstad, Camilla; Ånensen, Nina ; Gjertsen, Bjørn Tore; Døskeland, Stein Ove; Hedin, Lars Flemming (2003). Myeloid leukemia cell differentiation by bcl-2 and camp involves induction of ccaat/enhancer binding protein ? (c/ebp?), nuclear accumulation of c/ebp?, and direct interaction between bcl-2 and c/ebp?. The Fourth International Conference on Mechanisms of Cell Death and Disease: Advances in Therapeutic Intervention and Drug Development.
https://hdl.handle.net/11250/3463635



These publications are obtained from Norwegian Research Information Repository. The list may be incomplete.
P.O. Box 4, St. Olavs plass
NO-0130 Oslo
Norway
Tel.: +47 67 23 50 00
Contact us